297 related articles for article (PubMed ID: 6890464)
1. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
Sibley DR; Weinberger S; Segal DS; Creese I
Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
[No Abstract] [Full Text] [Related]
2. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
Riffee WH; Wilcox RE; Vaughn DM; Smith RV
Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
[TBL] [Abstract][Full Text] [Related]
3. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
Robertson HA
Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
[TBL] [Abstract][Full Text] [Related]
4. Interactions of a partial ergoline with dopamine receptors in vivo and in vitro.
Fuxe K; Goldstein M; Agnati LF; Köhler C; Lew JY; Okada K
Acta Physiol Scand; 1983 Feb; 117(2):303-5. PubMed ID: 6869037
[No Abstract] [Full Text] [Related]
5. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
Seeman P; Grigoriadis D
Biochem Pharmacol; 1985 Nov; 34(22):4065-6. PubMed ID: 4062976
[No Abstract] [Full Text] [Related]
6. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
Ritzmann RF; Lee JM; Fields JZ
Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
[No Abstract] [Full Text] [Related]
7. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
Korf J; Sebens JB; Flentge F; van der Werf JF
J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
[TBL] [Abstract][Full Text] [Related]
8. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M
Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097
[TBL] [Abstract][Full Text] [Related]
9. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
10. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
[TBL] [Abstract][Full Text] [Related]
11. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
12. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
[No Abstract] [Full Text] [Related]
13. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.
Trulson ME; Crisp T
Eur J Pharmacol; 1985 Nov; 117(2):267-70. PubMed ID: 4076345
[TBL] [Abstract][Full Text] [Related]
14. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
Creese I; Snyder SH
Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
[TBL] [Abstract][Full Text] [Related]
15. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
Clements-Jewery S; Robson PA
Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
[No Abstract] [Full Text] [Related]
16. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
Bhargava HN
Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
[TBL] [Abstract][Full Text] [Related]
17. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
[No Abstract] [Full Text] [Related]
18. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
Akiyama K; Sato M; Otsuki S
Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
Near JA; Mahler HR
J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
[No Abstract] [Full Text] [Related]
20. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
Agnati LF; Fuxe K; Battistini N; Benfenati F
Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
